Prevention of deep infection in joint replacement surgery: A review

Acta Orthopaedica

Volumn 81, Issue 6, 2010, Pages 660-666

  Jämsen, Esa ^a,b   Furnes, Ove ^c,d   Engesæter, Lars B ^c,d   Konttinen, Yrj T ^a,e   Odgaard, Anders ^f   Stefánsdttir, Anna ^g   Lidgren, Lars ^g  

^a Hospital for Joint Replacement   (Finland)

^b Seinjoki Central Hospital   (Finland)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFUROXIME; CHLORHEXIDINE; CLINDAMYCIN; LOW MOLECULAR WEIGHT HEPARIN; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; BATH; CLINICAL TRIAL; DEEP INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; KNEE ARTHROPLASTY; PATHOGENESIS; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TOTAL HIP PROSTHESIS;

ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; HUMANS; INCIDENCE; PERIOPERATIVE CARE; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; REGISTRIES; REOPERATION; RISK FACTORS; SCANDINAVIA;

EID: 78649662117     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2010.537805     Document Type: Review

References (65)

1. AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg (Br) 2008; 90 (7): 915-9.
2. Asensio A, Ramos A, Múñez E, Vilanova J L, Torrijos P, García F J. Preop-erative low molecular weight heparin as venous thromboembolism proph-ylaxis in patients at risk for prosthetic infection after knee arthroplasty. Infect Control Hosp Epidemiol 2005; 26 (12): 903-9.
3. Australian Orthopaedic Association. National Joint Registry. Annual Report. Australian Orthopaedic Association, Adelaide 2009. Available online at www.aoa.org.au.
4. Bedouch P, Labarère J, Chirpaz E, Allenet B, Lepape A, Fourny M, Pavese P, Girardet P, Merloz P, Saragaglia D, Calop J, Francois P. Compliance with guidelines on antibiotic prophylaxis in total hip replacement surgery: results of a retrospective study of 416 patients in a teaching hospital. Infect Control Hosp Epidemiol 2004; 25 (4): 302-7.
5. van de Belt H, Neut D, Schenk W, van Horn J R, van der Mei H C, Busscher H J. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001; 72 (6): 557-71.
6. Brandt C, Hott U, Sohr D, Daschner F, Gastmeier P, Rüden H. Operating room ventilation with laminar airfow shows no protective effect on the surgical site infection rate in orthopedic and abdominal surgery. Ann Surg 2009; 248 (5): 695-700.
7. Chiu F Y, Lin C F. Antibiotic-impregnated cement in revision total knee arthroplasty. A prospective cohort study of one hundred and eighty-three knees. J Bone Joint Surg (Am) 2009; 91 (3): 628-33.
8. Chiu F Y, Lin C F, Chen C M, Lo W H, Chaung T Y. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospec-tive, randomised study. J Bone Joint Surg (Br) 2001; 83 (5): 691-5.
9. Chiu F Y, Chen C M, Lin C F, Lo W H. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg (Am) 2002; 84 (5): 759-62.
10. Dale H, Hallan G, Espehaug B, Havelin L I, Engesæter L B. Increasing risk for revision due to deep infection after hip arthroplasty. A study on 97,344 primary total hip replacements in the Norwegian Arthroplasty Register from 1987 to 2007. Acta Orthop 2009, 80 (6): 639-45.
11. David T S, Vrahas M S. Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg 2000; 8 (1): 66-74.
12. Dobzyniak M, Fehring T K, Odum S. Early failure in total hip arthroplasty. Clin Orthop 2006; (447): 76-8.
13. Dowsey M M, Choong P F. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop 2009; 467 (6): 1577-81.
14. Edwards P, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database of Sys-tematic Reviews 2009; (4): CD003949.
15. Engesæter L B, Lie S A, Espehaug B, Furnes O, Vollset S E, Havelin L I. Anti-biotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74 (6): 644-51.
16. Espehaug B, Engesæter L B, Vollset S E, Havelin L I, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg (Br) 1997; 79 (4): 590-5.
17. Fehring T K, Odum S M, Griffn W L, Mason J B, McCoy T H. The obes-ity epidemic: its effect on total joint arthroplasty. J Arthroplasty (Suppl 2) 2007; 22 (6): 71-6.
18. Fletcher N, Sofanos D, Berkes M B, Obremskey W T. Prevention of periop-erative infection. J Bone Joint Surg (Am) 2007; 89 (7): 1605-18.
19. Forbes S S, Eskicioglu C, Nathens A B, Fenech D S, Lafamme C, McLean R F, McLeod R S; Best Practice in General Surgery Committee, University of Toronto. Evidence-based guidelines for prevention of perioperative hypo-thermia. J Am Coll Surg 2009; 209 (4): 492-503.
20. Furnary A P, Wu Y. Eliminating the diabetic disadvantage: the Portland Dia-betic Project. Semin Thorac Cardiovasc Surg 2006; 18 (4): 302-8.
21. Furnes O, Espehaug B, Lie S A, Vollset S E, Engesæter L B, Havelin L I. Failure mechanisms after unicompartmental and tricompartmental primary knee replacement with cement. J Bone Joint Surg (Am) 2007; 89 (3): 519-25.
22. Galat D D, McGovern S C, Larson D R, Harrington J R, Hanssen A D, Clarke H D. Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg (Am) 2009; 91 (1): 48-54.
23. Gastmeier P, Sohr D, Brandt C, Eckmanns T, Behnke M, Rüden H. Reduction of orthopaedic wound infections in 21 hospitals. Arch Orthop Trauma Surg 2005; 125 (8): 526-30.
24. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54 (4): 258-66.
25. Haynes A B, Weiser T G, Berry W R, Lipsitz S R, Breizat A H, Dellinger E P, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009; 360 (5): 491-9.
26. Huotari K, Lyytikäinen O, Ollgren J, Virtanen M J, Seitsalo S, Palonen R, Rantanen P, the Hospital Infection Surveillance Team. Disease burden of prosthetic joint infections after hip and knee joint replacement in Finland during 1999-2004: capture-recapture analysis. J Hosp Infect 2010; 75 (3): 205-8.
27. Jämsen E. Epidemiology of infected knee replacement [doctoral dissertation]. Acta Universitatis Tamperensis 1386. Tampere University Press, Tampere 2009. Available online at http://acta.uta.f/english/teos.php?id=11164
28. Jämsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg (Am) 2009a; 91 (1): 38-47.
29. Jämsen E, Huotari K, Huhtala H, Nevalainen J, Konttinen Y T. Low rate of infected knee replacements in a nationwide series-is it an underestimate? Acta Orthop 2009b; 80 (2): 205-12.
30. Jämsen E, Varonen M, Huhtala H, Lehto M U, Lumio J, Konttinen Y T Moilanen T. Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty 2010; 25 (1): 87-92.
31. van Kasteren M E, Manniën J, Ott A, Kullberg B J, de Boer A S, Gyssens I C. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis 2007; 44 (7): 921-7.
32. Konttinen Y T, Seitsalo S, Lehto M, Santavirta S. Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs. Acta Orthop 2005; 76 (5): 614-9.
33. Lai K, Bohm E R, Burnell C, Hedden D R. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty 2007; 22 (5): 651-6.
34. Lidwell O M, Elson R A, Lowbury E J, Whyte W, Blowers R, Stanley S J, Lowe D. Ultraclean air and antibiotics for prevention of postoperative infection. A multicenter study of 8,052 joint replacement operations. Acta Orthop Scand 1987; 58 (1): 4-13.
35. Ljungqvist O, Soop M, Hedström M. Why metabolism matters in elective orthopedic surgery: a review. Acta Orthop 2007; 78 (5): 610-5.
36. Mangram A J, Horan T C, Pearson M L, Silver L C, Jarvis W R. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Com-mittee. Am J Infect Control 1999; 27 (2): 97-132.
37. Marchant M H Jr, Viens N A, Cook C, Vail T P, Bolognesi M P. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg (Am) 2009; 91 (7): 1621-9.
38. Meding J B, Klay M, Healy A, Ritter M A, Keating E M, Berend M E. The prescreening history and physical in elective total joint arthroplasty. J Arthroplasty (Suppl 2) 2007; 22 (6): 21-3.
39. Muilwijk J, van den Hof S, Wille J C. Associations between surgical site infection risk and hospital operation volume and surgeon operation volume among hospitals in the Dutch nosocomial infection surveillance network. Infect Control Hosp Epidemiol 2007; 28 (5): 557-63.
40. Mulhall K J, Ghomrawi H M, Scully S, Callaghan J J, Saleh K J. Current etiologies and modes of failure in total knee arthroplasty revision. Clin Orthop 2006; (446): 45-50.
41. Møller A M, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clini-cal trial. Lancet 2002; 359 (9301): 114-7.
42. Parker M J, Livingstone V, Clifton R, McKee A. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database of System-atic Reviews 2007; (3): CD001825.
43. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replace-ment: a retrospective review of 6489 total knee replacements. Clin Orthop 2001; (392): 15-23.
44. Persson U, Persson M, Malchau H. The economics of preventing revisions in total hip replacement. Acta Orthop Scand 1999; 70 (2): 163-9.
45. Phillips J E, Crane T P, Noy M, Elliott T S, Grimer R J. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospec-tive survey. J Bone Joint Surg (Br) 2006; 88 (7): 943-8.
46. Pili-Floury S, Mitifot F, Penfornis A, Boichut N, Tripart M H, Christophe J L, Garbuio P, Samain E. Glycaemic dysregulation in nondiabetic patients after major lower limb prosthetic surgery. Diabetes Metab 2009; 35 (1): 43-8.
47. Pulido L, Ghanem E, Joshi A, Purtill J J, Parvizi J. Periprosthetic joint infec-tion: the incidence, timing, and predisposing factors. Clin Orthop 2008; (466) (7): 1710-5.
48. Reeves M, Skinner M W. Continuous intra-articular infusion of ropivacaine after unilateral total knee arthroplasty. Anaesth Intensive Care 2009; 37 (6): 918-22.
49. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg (Br) 2005; 87 (6): 844-50.
50. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database of Systematic Reviews 2008; (4): CD006216.
51. Schrama J C, Espehaug B, Hallan G, Engesæter L B, Furnes O, Havelin L I, Fevang B T. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared to patients with osteoarthritis. Arthritis Care Res 2010; 62 (4): 473-9.
52. Scottish Intercollegiate Guidelines Network. Antibiotic prophylaxis in sur-gery. A national clinical guideline. Scottish Intercollegiate Guidelines Net-work, Edinburgh 2008.
53. Shervin N, Rubash H E, Katz J N. Orthopaedic procedure volume and patient outcomes: a systematic literature review. Clin Orthop 2007; (457): 35-41.
54. Stefánsdóttir A, Johansson D, Knutson K, Lidgren L, Robertsson O. Micro-biology of the infected knee arthroplasty. Report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases. Scand J Infect Dis 2009a; 41 (11-12): 831-40.
55. Stefánsdóttir A, Robertsson O, W-Dahl A, Kiernan S, Gustafson P, Lidgren L. Inadequate timing of prophylactic antibiotics in orthopedic surgery. We can do better. Acta Orthop 2009b; 80 (6): 633-8.
56. Swedish Knee Arthroplasty Register. Annual report 2009. Lund University Hospital, Lund 2009. Available online at www.knee.se/.
57. Sørensen L T, Karlsmark T, Gottrup F. Abstinence from smoking reduces inci-sional wound infection: a randomized controlled trial. Ann Surg 2003; 238 (1): 1-5.
58. Tomita M, Motokawa S. Effects of air tourniquet on the antibiotics concen-tration, in bone marrow, injected just before the start of operation. Mod Rheumatol 2007; 17 (5): 409-12.
59. Uçkay I, Pittet D, Bernard L, Lew D, Perrier A, Peter R. Antibiotic prophy-laxis before invasive dental procedures in patients with arthroplasties of the hip and knee. J Bone Joint Surg (Br) 2008; 90 (7): 833-8.
60. Webb A L, Flagg R L, Fink A S. Reducing surgical site infections through a multidisciplinary computerized process for preoperative prophylactic anti-biotic administration. Am J Surg 2006; 192 (5): 663-8.
61. Weber W P, Marti W R, Zwahlen M, Misteli H, Rosenthal R, Reck S, Fueg-listaler P, Bolli M, Trampuz A, Oertli D, Widmer A F. The timing of surgi-cal antimicrobial prophylaxis. Ann Surg 2008; 247 (6): 918-26.
62. Webster J, Alghamdi A A. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev 2009; (4): CD006353.
63. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2007; (2): CD004985.
64. Yano K, Minoda Y, Sakawa A, Kuwano Y, Kondo K, Fukushima W, Tada K. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop 2009, 80 (4): 486-90.
65. Zimmerli W, Trampuz A, Ochsner P E. Prosthetic-joint infections. N Engl J Med 2004; 351 (16): 1645-54.